https://www.selleckchem.com/TGF-beta.html
In the developed world, 5-years survival of childhood acute myeloid leukaemia (AML) has improved to 70%. However, the survival rates in the developing world are below 40%. The main contributing factors to these reduced survival rates are a late presentation, malnutrition and high treatment-related mortality. To document the factors affecting treatment outcome of childhood AML at a tertiary care facility of Pakistan. All newly registered cases of AML under 18 years of age from January 1, 2012 onwards who completed their treatment before November
Like
Comment
Share
